Rite Aid Corporation (RAD)
Company Description
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States.
The company operates through two segments, Retail Pharmacy and Pharmacy Services.
The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line.
It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects.
In addition, this segment offers healthcare coaching and disease management services to health plans and employers.
The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups.
This segment serves health plans, commercial employers, labor groups, and state and local governments.
As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states.
Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

Country | United States |
IPO Date | Mar 17, 1980 |
Industry | Medical - Pharmaceuticals |
Sector | Healthcare |
Employees | 47,000 |
CEO | Elizabeth H. Burr |
Contact Details
Address: 1200 Intrepid Avenue Philadelphia, Pennsylvania United States | |
Website | https://www.riteaid.com |
Stock Details
Ticker Symbol | RAD |
Exchange | NYSE |
Fiscal Year | March - February |
Reporting Currency | USD |
CIK Code | 0000084129 |
CUSIP Number | 767754872 |
ISIN Number | US7677548726 |
Employer ID | 23-1614034 |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Elizabeth H. Burr | Interim Chief Executive Officer & Director |
Heyward Rutledge Donigan B.A. | Pres, Chief Executive Officer & Director |
Matthew C. Schroeder | Chief Financial Officer & Executive Vice President |
Paul D. Gilbert | Executive Vice President, Gen. Counsel, Chief Legal Officer & Corporation Sec. |
Thomas J. Sabatino Jr. | Executive Vice President & Chief Legal Officer |
Angele Robinson-Gaylord | Senior Vice President of Store Devel. |
Brian T. Hoover | Chief Accounting Officer & Senior Vice President |
Byron Purcell | Vice President of Investor Relations & Treasurer |
Christopher S. Hall | Senior Vice President of Pharmacy Services |
Daniel Miller | Senior Vice President of Pharmacy Regulatory Affairs |
Frank G. Vitrano | Chief Strategic Bus. Devel. Officer |
Jeanniey Walden | Senior Vice President & CMO |
Jessica Kazmaier | Executive Vice President & Chief HR Officer |
Joy Errico Seusing | Senior Vice President & Chief Communications Officer |
Justin L. Mennen | Executive Vice President and Chief Technology & Digital Officer |
Karen Lesley Staniforth | Senior Vice President of Clinical Pharmacy Services & Chief Pharmacy Officer |
Mark Kramer | Senior Vice President of NY Metro Division |
Scott Bernard | Senior Vice President of Eastern Division |
Steve Bixler | Chief Accounting Officer |
Steven K. Bixler | Chief Accounting Officer & Senior Vice President |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 03, 2025 | 15-12G | Filing |
Sep 12, 2024 | SC 13D | Filing |
Sep 09, 2024 | SC 13D | Filing |
Sep 09, 2024 | SC 13D | Filing |
Sep 09, 2024 | 3 | Filing |
Sep 09, 2024 | SC 13D | Filing |
Sep 09, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Sep 09, 2024 | SC 13D | Filing |
Aug 30, 2024 | SEC STAFF ACTION | Filing |
Aug 30, 2024 | T-3/A | [Amend] Filing |